AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07027488 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma and Normal or Impaired
Advanced Melanoma

Interventions

DRUG: AB821

Sponsor

Yale University

Collaborators

[object Object]